Bioregenx (BRGX) Net Cash Flow (2022 - 2026)
Bioregenx's (BRGX) quarterly Net Cash Flow came in at -$23577.0 in Q1 2026, down 186.43% year-on-year from $27280.0 in Q1 2025, and down 205.09% quarter-over-quarter from $22436.0 in Q4 2025.
Bioregenx (BRGX) Net Cash Flow (2022 - 2026) Analysis & Trends
Bioregenx's Net Cash Flow history runs 5 years deep, the most recent figure standing at -$23577.0 for Q1 2026.
- On a quarterly basis, Net Cash Flow fell 186.43% year-over-year to -$23577.0 in Q1 2026; TTM through Mar 2026 was -$37844.0, a 24.45% decrease from a year earlier, with the FY2025 full-year figure at $13013.0, up 118.6% from the prior year.
- Net Cash Flow retreated to -$23577.0 in Q1 2026 per BRGX's latest filing, from $22436.0 in the prior quarter.
- Across five years, Net Cash Flow topped out at $68381.0 in Q4 2023 and bottomed at -$239056.0 in Q2 2023.
- The 5-year median for Net Cash Flow is -$12285.0 (2024), against an average of -$36135.5.
- Biggest YoY gain for Net Cash Flow was 8005.32% in 2023; the steepest drop was 28655.33% in 2023.
- Year by year, Net Cash Flow stood at -$865.0 in 2022, then jumped by 8005.32% to $68381.0 in 2023, then tumbled by 122.89% to -$15653.0 in 2024, then soared by 243.33% to $22436.0 in 2025, then sank by 205.09% to -$23577.0 in 2026.
- Per Business Quant, the three latest BRGX Net Cash Flow figures stand at -$23577.0 (Q1 2026), $22436.0 (Q4 2025), and -$6731.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 29.34 Bn | 22.03 Bn | 662.02 Mn | 475.88 Mn |
| 2 | BrightSpring Health Services | 13.49 Bn | 12.59 Bn | 482.22 Mn | 800.32 Mn |
| 3 | Healthequity | 7.96 Bn | 7.70 Bn | 256.31 Mn | -53.56 Mn |
| 4 | 10x Genomics | 6.17 Bn | 5.63 Bn | 106.18 Mn | 16.39 Mn |
| 5 | Hinge Health | 6.02 Bn | 5.70 Bn | 154.23 Mn | -21.68 Mn |
| 6 | MiniMed | 4.19 Bn | 3.89 Bn | 480.00 Mn | 286.00 Mn |
| 7 | Waystar Holding | 4.14 Bn | 4.07 Bn | 216.84 Mn | -14.11 Mn |
| 8 | Doximity | 3.82 Bn | 3.08 Bn | 125.97 Mn | 154.34 Mn |
| 9 | Privia Health | 3.10 Bn | 2.73 Bn | - | -60.16 Mn |
| 10 | Bioregenx | 9.69 Mn | 9.65 Mn | 348,288.00 | -23,577.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,577.00 |
| Mar 31, 2026 | -23,577.00 |
| Dec 31, 2025 | 22,436.00 |
| Dec 31, 2025 | 22,436.00 |
| Sep 30, 2025 | -6,731.00 |
| Sep 30, 2025 | -6,731.00 |
| Jun 30, 2025 | -29,972.00 |
| Jun 30, 2025 | -29,972.00 |
| Mar 31, 2025 | 27,280.00 |
| Mar 31, 2025 | 27,280.00 |
| Dec 31, 2024 | -15,653.00 |
| Dec 31, 2024 | -15,653.00 |
| Sep 30, 2024 | 15,246.00 |
| Sep 30, 2024 | 15,246.00 |
| Jun 30, 2024 | -57,282.00 |
| Jun 30, 2024 | -57,282.00 |
| Mar 31, 2024 | -12,285.00 |
| Mar 31, 2024 | -12,285.00 |
| Dec 31, 2023 | 68,381.00 |
| Dec 31, 2023 | 68,381.00 |